Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corporate Profile for EDAP Technomed, dated Oct. 3, 1997.


--(BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-

Published Date:   Oct 3, 1997

Company Name:     EDAP Technomed, Inc

Address:          Two Burlington Woods
                  Burlington, MA 01803

Main Telephone
 Number:          781/221-1601

Internet Home
 Page Address
  (URL):          www.edaptechnomed.com

Chief Executive
 Officer:         Robert J. Minton, President

Chief Financial
 Officer:         Paul T. More, Vice President

Investor Relations
 and
 Public Relations
 Contact:         Christine Meehan, Senior Vice President
 Business number: 781/221-1601

Public Relations
  Contact:        Eileen F. Pacheco, Director of Public Relations
                  Marketing Strategies Inc.
Business number:  781/356-5090

Trading Symbol/
 Exchange:        NASDAQ:EDAPY

Industry:         Medical devices: Develop, manufacture, and market
                  urological medical equipment





Company description: Founded in 1979, EDAP EDAP Eating Disorders Awareness and Prevention
EDAP Extended Data Availability and Protection (fault tolerant disk technology)
EDAP Emergency Department Approved for Pediatrics
EDAP Energy Descent Action Plan
 Technomed, Inc. is a pioneer in the development of minimally invasive, cost-effective medical therapies, primarily for the treatment of urological diseases. The Company currently produces and markets devices for the treatment of benign prostatic hyperplasia benign prostatic hyperplasia
n. Abbr. BPH
A nonmalignant enlargement of the prostate gland commonly occurring in men after the age of 50, and sometimes leading to compression of the urethra and obstruction of the flow of urine.
 (BPH BPH
abbr.
benign prostatic hyperplasia


BPH
Benign prostatic hypertrophy, a very common noncancerous cause of prostatic enlargement in older men.
) and urinary tract stones. The Company is also developing products for minimally invasive destruction of certain types of tumors.

EDAP Technomed's Prostatron(R) is the first device approved by the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 for use in TransUrethral Microwave Thermotherapy ther·mo·ther·a·py
n.
Medical therapy involving the application of heat.


thermotherapy
 (TUMT<R>), a non-surgical, one-hour, outpatient treatment for BPH, the non-cancerous enlargement of the prostate which affects 50% of men over age 60. More than 150 hospitals and medical centers worldwide are treating BPH patients with Prostatron.

The Company also manufactures and distributes lithotripters based on extra-corporeal shockwave lithotripsy (ESWL ESWL (Extracorporeal shock wave lithotripsy)
The use of focused shock waves, generated outside the body, to fragment kidney stones.

Mentioned in: Lithotripsy
) technology, for the treatment of kidney stones. With more than 400 lithotripters installed around the world, EDAP Technomed is among the top three lithotripsy companies worldwide.

EDAP Technomed's development of new therapies and devices for the microwave thermotherapy, lithotripsy and high-frequency ultrasound (HIFU HIFU High-intensity focused ultrasound Surgery A method that focuses ultrasound to heat/ablate target tissue without injuring surrounding structures. See Sonablate 200™. ) markets is supported by strategic alliances with top medical research institutes around the world. This partnership approach has contributed to the impressive pace and cost-effectiveness of reliable new therapies that EDAP Technomed has brought to market.

Headquartered in Burlington, Massachusetts, EDAP Technomed, Inc. is the U.S. operating company of publicly held Paris, France-based EDAP TMS TMS Transcranial Magnetic Stimulation (alternative medicine for depression)
TMS Test Match Special (sports - cricket)
TMS Texas Motor Speedway
TMS Transportation Management System
TMS Toyota Motor Sales
 S.A. (NASD NASD

See: National Association of Securities Dealers


NASD

See National Association of Securities Dealers (NASD).
:EDAPY), a world leader in the fields of microwave thermotherapy and lithotripsy.

CONTACT: EDAP Technomed
COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 3, 1997
Words:380
Previous Article:Source Services Corporation Awarded Price Agreement by State of Colorado.
Next Article:Corporate Profile for COGENT, dated Oct. 3, 1997.
Topics:



Related Articles
In-line treatment cuts Acme Foundry's disposal costs by 90%.
EDAP Technomed creates joint venture as a result of Prostatron reimbursement decision.
EDAP Technomed OK's licensing deal for its microwave technology.
Prostatron receives CE certification.
Prime Medical Services, Inc. announces Prostatron joint venture.
EDAP Technomed Selects American MedTech for Nationwide Urology Treatment Equipment Maintenance Services.
Prime Medical Services, Inc. Announces Vertical Integration Investment.
EDAP Technomed Adds Cleveland Clinic to Nationwide Network of Prostatron Sites.
EDAP Technomed, Inc. Comments on Recalculated Rate for Office-Based TUMT-R-.
FDA ALLOWS HEAT TREATMENT FOR PROSTATE PROBLEM.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles